UTHR United Therapeutics Corporation Common Stock

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
UTHR Fundamental Data
Loading...
Similar Companies
Loading...
UTHR Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
UTHR Insider Transactions
Loading insider data…
UTHR News
Date Headline Sentiment
Liquidia Settles Bitter Fight With United Therapeutics
50.76%
Why Enovix Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
66.25%
Liquidia Corporation Stock Is Trending In After-Hours Following United Therapeutics Settlement: What You Should Know
61.37%
Liquidia Will Continue To Advance YUTREPIA And L606 Clinical Programs As Previously Outlined; Liquidia Has Submitted A Supplement To Remove The PH-ILD Indication From YUTREPIA’ ’s Label And No Longer Promotes It For PH-ILD
60.91%
Liquidia Enters Into A Global Settlement Agreement With United Therapeutics That Resolves All Pending Litigation Between The Companies; Settlement Fully Resolves Six Ongoing Lawsuits Between Liquidia And United Therapeutics; Liquidia To Pay Net $380.70M In Installments In 2026 And 2027; Liquidia Will Make A Net Payment To UTHR Of $175M Within 30 Business Days
61.65%
RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $708
89.84%
Morgan Stanley Maintains Equal-Weight on United Therapeutics, Raises Price Target to $566
72.34%
United Therapeutics shares are trading higher after the company confirmed a patent litigation legal judgement in its favor in a claim against Liquidia. Also, BTIG upgraded its rating on the stock from Neutral to Buy and announced a $728 price target.
94.45%
This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
79.67%
United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia
92.99%